Free Trial

Q2 Earnings Forecast for Enhabit Issued By Leerink Partnrs

Enhabit logo with Medical background

Enhabit, Inc. (NYSE:EHAB - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for Enhabit in a research report issued to clients and investors on Sunday, May 11th. Leerink Partnrs analyst W. Mayo anticipates that the company will earn $0.11 per share for the quarter. The consensus estimate for Enhabit's current full-year earnings is $0.22 per share. Leerink Partnrs also issued estimates for Enhabit's Q3 2025 earnings at $0.11 EPS, Q4 2025 earnings at $0.10 EPS, FY2025 earnings at $0.42 EPS, Q4 2026 earnings at $0.11 EPS, FY2026 earnings at $0.47 EPS and FY2027 earnings at $0.37 EPS.

Separately, Jefferies Financial Group reaffirmed a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Get Our Latest Report on EHAB

Enhabit Stock Performance

NYSE:EHAB traded down $0.03 during trading on Wednesday, reaching $10.62. The company's stock had a trading volume of 166,309 shares, compared to its average volume of 461,483. The firm has a market cap of $537.51 million, a price-to-earnings ratio of -4.57 and a beta of 1.61. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a 50 day moving average of $8.53 and a 200-day moving average of $8.21. Enhabit has a 12 month low of $6.85 and a 12 month high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.03. The business had revenue of $259.90 million during the quarter, compared to the consensus estimate of $266.11 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Enhabit by 4.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,565 shares of the company's stock worth $223,000 after acquiring an additional 1,216 shares during the period. Mackenzie Financial Corp lifted its holdings in Enhabit by 12.1% during the 1st quarter. Mackenzie Financial Corp now owns 14,468 shares of the company's stock worth $127,000 after purchasing an additional 1,564 shares in the last quarter. Rhumbline Advisers lifted its holdings in Enhabit by 2.8% during the 4th quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock worth $631,000 after purchasing an additional 2,211 shares in the last quarter. Magnetar Financial LLC lifted its holdings in Enhabit by 10.4% during the 1st quarter. Magnetar Financial LLC now owns 24,168 shares of the company's stock worth $212,000 after purchasing an additional 2,281 shares in the last quarter. Finally, Stoneridge Investment Partners LLC lifted its holdings in Enhabit by 22.6% during the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after purchasing an additional 2,308 shares in the last quarter.

About Enhabit

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Recommended Stories

Earnings History and Estimates for Enhabit (NYSE:EHAB)

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines